WASHINGTON, Dec. 12 -- Food and Drug Administration has issued a notice called: Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use.

The notice was published in the Federal Register on Dec. 12 by Lowell M. Zeta, Acting Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: In response to an over-the-counter (OTC) monograph order request (OMOR), the Food and Drug Administration (FDA) is announcing the availability on its website of the proposed administrative order (proposed order) (OTC000039) entitled "Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use." This proposed order, if finalized, will amend Over-the-Counter Monogra...